This is an average of the three domain scores below.
The U.S. Government received an 86 (B) with transparency and an 88 (B+) without transparency for HIV and AIDS in 2017. This grade reflects the expansion of the Global Gag Rule (GGR) via Presidential Memorandum which substantially hindered sexual and reproductive health and rights (SRHR). The grade also considered guidance documents issued in 2017 by the President’s Emergency Plan for AIDS Relief (PEPFAR) that moderately promoted SRHR. The domain grade for HIV and AIDS-related funding and policies remained higher than the grades of the other domains across actors.
The White House received a 90 (A-) with transparency and a 90 (A-) without transparency for HIV and AIDS. Despite the negative impact of the Global Gag Rule on the global HIV and AIDS response, the White House recommended a high level of funding for HIV and AIDS in 2017.
Congress received an 88 (B+) with transparency and a 90 (A-) without transparency for HIV and AIDS. While no significant legislation related to HIV and AIDS was passed or amended in 2017, Congress appropriated less funding for HIV and AIDS programs than previous years but has relatively high transparency in these funding data.
The Department of State received a 90 (A-) with transparency and a 90 (A-) without transparency for HIV and AIDS because newly published PEPFAR policy documents moderately promoted SRHR through the HIV and AIDS response and funds for HIV and AIDS were spent in a way that was responsive to global need in 2017.
USAID received a 95 (A) with transparency and a 96 (A) without transparency for HIV and AIDS. While no new HIV and AIDS-related policy was released in 2017, the Agency spent HIV and AIDS funding in a way that was highly responsive to need.
HHS received a 69 (D+) with transparency and a 75 (C) without transparency for HIV and AIDS in 2017 because it had very low transparency of policy information and unavailable funding data.
The DoD received a 69 (D+) with transparency and 75 (C) without transparency for HIV and AIDS in 2017 because it had very low transparency of policy information and unavailable funding data.